Target intelligence / Profile preview

Potassium voltage-gated channel subfamily KQT member 4 (Kv7.4) (Kv7.4)

Target
Kv7.4
Molecular classification
Ion channel, Voltage-gated potassium channel, KCNQ family
01

Overview

Potassium voltage-gated channel subfamily KQT member 4 (Kv7.4) is a transmembrane protein encoded by the KCNQ4 gene that functions as a voltage-dependent potassium channel. It is predominantly expressed in the outer hair cells of the cochlea and the vestibular system, where it plays a critical role in recycling potassium ions and maintaining the electrical properties necessary for auditory transduction (UniProt O43526). Mutations in this channel are the primary cause of DFNA2, a form of progressive, nonsyndromic sensorineural hearing loss (Kubisch et al., 1999, PMID: 10072428). In addition to its role in the ear, Kv7.4 is expressed in vascular smooth muscle and certain brainstem neurons, influencing vascular resistance and central auditory processing (Jepps et al., 2011, PMID: 21670110). Therapeutic interest in Kv7.4 focuses on the development of selective activators to treat hearing loss and tinnitus by stabilizing the membrane potential of hair cells. However, achieving selectivity is challenging due to the high structural homology between Kv7.4 and other members of the KCNQ family, which can lead to cardiovascular or neurological side effects (Gunthorpe et al., 2012, PMID: 22407153).

Other names
KCNQ4Potassium channel subunit alpha Kv7.4DFNA2DFNA2AVoltage-gated potassium channel subunit Kv7.4
02

Mechanism of action

Positive allosteric modulation to increase channel opening probability or shift voltage-dependence of activation; pore blockade for inhibition.

03

Biological functions

Potassium ion transportRegulation of membrane potentialSensory perception of soundNeuronal excitabilityRegulation of vascular tone
04

Disease associations

Nonsyndromic sensorineural hearing lossTinnitusHypertension
05

Safety considerations

Off-target effects on Kv7.1 (cardiac)Off-target effects on Kv7.2/3 (CNS)Urinary retentionDizzinessSomnolence
06

Interacting drugs

Retigabine

5 more in the full profile.

07

Biomarkers

KCNQ4 gene mutationAudiometric thresholds

Beyond the preview

Go deeper on Potassium voltage-gated channel subfamily KQT member 4 (Kv7.4) (Kv7.4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium voltage-gated channel subfamily KQT member 4 (Kv7.4) (Kv7.4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call